Insertion of a testicular prosthesis at the time of radical orchiectomy for testicular cancer is safe in patients who will subsequently undergo chemotherapy or radiotherapy

Abstract

We aimed to assess the incidence of prosthesis‐related complications in patients who received a testicular prosthesis at the time of radical orchiectomy for testicular cancer and were then treated with chemotherapy (ChT) or radiotherapy (RT). We reviewed the records of the patients who underwent radical orchiectomy at our Institute since 1999; we also retrieved data from patients who underwent surgery elsewhere and then received ChT or RT at our Institution since 1999. We used the chi‐square test to evaluate differences in the incidence of prosthesis‐related complications between the groups. We retrieved the records of 587 patients; 393 had a testicular prosthesis implanted. Median follow‐up was 57.7 months. One hundred thirty‐eight patients (35.11%) received ChT, 129 RT (38.82%) and 10 (2.55%) both ChT and RT; of them, 6 (4.34%), 8 (6.20%) and 0 reported problems respectively. Seven (6.03%) of the 116 patients (29.52%) who had no further treatment had complications. The incidence of complications was not significantly different between patients who had no further treatment versus patients who underwent ChT (p = .75) or RT (p = .83). Testicular prosthesis insertion at the time of radical orchiectomy is safe even in patients subsequently undergoing ChT or RT.

Cost and utilization analysis of concurrent versus staged testicular prosthesis implantation for radical orchiectomy

“…It has been previously demonstrated that concurrent insertion of testicular prosthesis during radical orchiectomy is safe, and this extra procedure does not increase the complication rate as determined by length of stay (p = 0.387), hospital readmission rates (p = 0.539), or reoperation (p = 0.999) compared to radical orchiectomy alone [ 15 ]. Another study demonstrated that concurrent implantation is safe even in the setting of adjuvant therapy, with no difference in complication rates between patients who did not undergo adjuvant treatment versus those who underwent chemotherapy (p = 0.75) or radiation (p = 0.83) [ 16 ]. Ours is the first study to directly compare the cost and clinical outcomes between a concurrent versus staged approach.…”

Complications of testicular prosthetics: analysis of causes, surgical tactics, ways of prevention

“…В исследованиях последних лет продемонстрировано, что частота осложнений у данной категории пациентов не превышает таковую в иных группах пациентов [10]. G. Musi (2020) По данным S. Marshall, наиболее частым осложнением является экструзия импланта -3-8 %; среди других осложнений отмечены высокое стояние импланта -3-5 %, болевой синдром -1-3 %, гематомы -0,3-3 %, инфекционные осложнения -0,6-2 % [12]. Сходные данные о частоте экструзии сообщают и другие авторыдо 5,2 % [13].…”